3.71
-0.32 (-7.94%)
| Penutupan Terdahulu | 4.03 |
| Jumlah Dagangan | 161,315 |
| Harga / Jualan (P/S) | 90.99 |
| Harga / Buku (P/B) | 0.530 |
| Julat 52 Minggu | |
| Hasil Dividen (DY TTM) | 6.74% |
| Margin Operasi (TTM) | -225.00% |
| EPS Cair (TTM) | -0.710 |
| Jumlah Hutang/Ekuiti (D/E MRQ) | 0.22% |
| Nisbah Semasa (MRQ) | 23.94 |
| Aliran Tunai Operasi (OCF TTM) | -10.46 M |
| Aliran Tunai Bebas Leveraj (LFCF TTM) | -1.51 M |
| Pulangan Atas Aset (ROA TTM) | -5.10% |
| Pulangan Atas Ekuiti (ROE TTM) | -18.51% |
AISkor Stockmoo
| Nilai 30% | 0.0 |
| Daripada penilaian laporan AI Insight kami tentang pulangan dijangka berbanding risiko. info | NA |
| Penilaian Relatif info | NA |
| Pertumbuhan Tersirat info | NA |
| Sejarah Penilaian info | NA |
| Hutang rendah. Keuntungan lemah. Kecairan jangka pendek mencukupi. Aliran tunai negatif. info | |
| Pulangan atas Modal info | NA |
| Masa 30% | -0.5 |
| Daripada analisis teknikal AI kami terhadap carta. info | NA |
| Aliran menaik sepanjang tahun lalu. Jauh di bawah paras tertinggi 52 minggu. info | |
| Corak Lilin info | NA |
| Aliran bagi Tempoh Pegangan Anda info | NA |
| Sentimen 20% | 0.0 |
| Tiada harga sasaran terkini, jadi berdasarkan arah semakan harga sasaran. info | |
| Sentimen Berita info | NA |
| Wang Pintar 20% | 3.2 |
| Aktiviti Orang Dalam info | NA |
| Institusi bersih +18.26% daripada saham dalam pemfailan 13F terkini: 56 pemegang menambah, 23 mengurang (suku berakhir 30 Sep 2026). info | |
| Kedudukan jual singkat +16.4% dari 31 Aug hingga 30 Oct 2026, 11.3 hari untuk tutup (FINRA). info | |
| Keadaan pasaran dan sektor lemah. | |
| Persekitaran pasaran berhati-hati. info | |
| Sektor ketinggalan berbanding pasaran. | |
| Tonggak-tonggak sependapat, jadi skor diperkukuh. | |
| Tidak dikira dalam skor | |
| Harga hampir dengan purata 52 minggunya. Turun dalam tempoh 5 tahun. info | |
| Momentum jangka pendek menurun. info | |
| Harga di antara sokongan dan rintangan. Paras sokongan dan rintangan menurun. info | |
| Skor Akhir | 0.46 |
Arah Aliran Pasaran
| Jangka Pendek | Jangka Sederhana | ||
| Industri | Biotechnology (US) | Bercampur | Menaik |
| Biotechnology (Global) | Bercampur | Menaik | |
| Stok | Oramed Pharmaceuticals Inc. | Bercampur | Bercampur |
Saham Serupa
| Stok | Modal Pasaran | DY | P/E (TTM) | P/B |
|---|---|---|---|---|
| ORMP | - | 6.74% | - | 0.530 |
| OPT | 583 M | - | - | 4.31 |
| OCUP | 51 M | - | - | 0.870 |
| CTMX | - | - | - | 1.55 |
| ZYME | - | - | - | 7.29 |
| PBYI | - | - | - | 2.73 |
|
Oramed Pharmaceuticals Inc is a pharmaceutical company that is engaged in the research and development of pharmaceutical solutions with a technology platform that allows for the oral delivery of therapeutic proteins. The company has developed an oral dosage form intended to withstand the harsh environment of the gastrointestinal tract and effectively deliver active insulin or other proteins. Its product pipeline includes ORMD-0801 for Diabetes, ORMD-0801 for NASH, and ORMD 0901. |
|
| Sektor | Healthcare |
| Industri | Biotechnology |
| Gaya Pelaburan | Small Core |
| % Dimiliki oleh Orang Dalam | 13.21% |
| % Dimiliki oleh Institusi | 19.12% |
Pemilikan
| Nama | Tarikh | Syer Dipegang |
|---|---|---|
| Sb Capital Management Inc | 31 Dec 2025 | 1,900,000 |
Tiada data dalam julat masa ini.
Tiada data dalam julat masa ini.
Institusi
Pemilikan institusi: 46.16%
| Kedudukan | Pemegang | Saham |
|---|---|---|
| Bertambah | 56 | 6,335,923 |
| Berkurang | 23 | 704,680 |
| Baharu | 23 | 2,573,118 |
| Dijual habis | 8 | 350,717 |
Pemfailan SEC 13F melalui Nasdaq, pemfailan terkini hingga 30 Sep 2026. Pemfailan tiba sehingga 45 hari selepas setiap suku.
Kedudukan Jual Singkat
| Penyelesaian | Saham | Hari untuk tutup |
|---|---|---|
| 30 Oct 2026 | 1,343,457 | 11.3 |
| 15 Oct 2026 | 1,451,095 | 10.4 |
| 30 Sep 2026 | 1,433,436 | 7.3 |
| 15 Sep 2026 | 1,307,745 | 7.4 |
| 31 Aug 2026 | 1,154,241 | 4.3 |
| 14 Aug 2026 | 1,025,767 | 5.9 |
Data jual singkat FINRA melalui Nasdaq, dilaporkan dua kali sebulan.
| Tarikh | Jenis | Butiran |
|---|---|---|
| 12 Nov 2026 | Yahoo Finance |
Oramed: Q3 Earnings Snapshot
NEW YORK (AP) — NEW YORK (AP) — Oramed Pharmaceuticals Inc. (ORMP) on Thursday reported profit of $134… |
| 08 Sep 2026 | Yahoo Finance |
Lifeward Publishes Updated Investor Presentation Highlighting Commercial Growth Strategy
HUDSON, Mass. and YOKNEAM ILLIT, Israel, Sept. 08, 2026 (GLOBE NEWSWIRE) -- Lifeward Ltd. (Nasdaq: LFWD) (“Lifeward” or the “Company”), a diversified biomedical innovation company with a portfolio of commercialized neurorehabilitation products and a biomedical pipeline, today announced that an… |
| 28 Aug 2026 | Yahoo Finance |
ORMP: Investment Gains Contributed to Strong 2Q26 EPS, While Inclusion in Russell Indexes Arguably Boosts Awareness
By M. Marin NASDAQ: ORMP READ THE FULL ORMP RESEARCH REPORT Gains on investment portfolio + service agreement income contributed to 2Q26 EPS of $2.76 Oramed Pharmaceuticals (NASDAQ: ORMP) leverages its strong balance sheet, with $15.2 million of cash and equivalents and $50.6 million of cash and… |
| 17 Aug 2026 | Yahoo Finance |
Nano Dimension Appoints Nadav Kidron to Board of Directors to Chair Strategy and Capital Allocation Committee
WALTHAM, Mass., Aug. 17, 2026 (GLOBE NEWSWIRE) -- Nano Dimension Ltd. (Nasdaq: NNDM) (“Nano Dimension,” “Nano,” or the “Company”) today announced the appointment of Nadav Kidron to its Board of Directors (the “Board”). As part of the Board’s ongoing strategic review, led by Chairman Phillip… |
| Hasil Dividen (DY TTM) | 6.74% |
| Jangkaan Pembayaran Dividen Seterusnya | Jan 2027 |
| Tarikh EX | Tarikh Pengumuman | Tarikh Pembayaran | Perincian |
|---|---|---|---|
| 16 Jan 2026 | - | 26 Jan 2026 | 0.25 Tunai |
Hasil Dividen Tahunan
| Tahun | Dividen Tahunan ($) | Kekerapan/Tahun | Hasil % |
|---|---|---|---|
| 2026 | 0.250 | 1 | 6.74 |
Portfolio
| Keuntungan Nyata | - |
| Keuntungan Tidak Nyata | - |
| Dividen Diterima 2026 | - |
| Jumlah Untung | - |
| Pulangan Purata | - |
| Kuantiti (Beli) | - |
| Purata Harga (Beli) | - |
| Kuantiti (Jual) | - |
| Purata Harga (Jual) | - |